Navigation Links
Amniotic Biologic Treatment for Erectile Dysfunction Deemed "Game Changer"

CORAL SPRINGS, Fla., Jan. 20, 2016 /PRNewswire/ -- "I feel like I regained a part of me that was missing." – Mr. S, recipient of biologics treatment for ED.

Photo -
Logo -

The first human study in the United States using amniotic biologics injected into the penis for Erectile Dysfunction was published this month in the January issue of The Journal of the American Osteopathic Association. 

The study showed a statistically significant improvement in blood flow into the penis that was sustained at 1 year after the injection.  Although the sample size is small, fellow Sexual Dysfunction experts are excited about the results.   

"Biological treatments for Erectile Dysfunction, Peyronie's Disease and beyond are the most cutting edge alternatives we can offer patients," says Brian L. Steixner M.D., Medical Director for the Institute for Men's Health, Jersey Urology Group.

The study performed by Dr. Michael Zahalsky and his team included 8 ED patients who received injections of placental derived stem cells and growth factors to promote wound healing, blood vessel formation, and tissue repair in the Corpora Cavernosum. 

Pre and post procedure, participants underwent a series of measurements. At six weeks, all 8 patients had improved blood flow into the penis, continuing to increase and reaching statistical significance at 3 months. By 3 months, 3 of the participants were getting erections on their own again.

"The use of these agents are the future in providing a cure for men struggling with a multitude of issues in sexual medicine," continues Dr. Steixner. "[Dr. Zahalsky's study] is a game changer."

"It's been amazing," continues Mr. S. "I've tried many other things beside the injections, and this is the first thing that has truly worked."

Dr. Zahalsky is a respected Urologist, dual fellowship trained at Boston University and MIT in Male Sexual Dysfunction.  Prior, he obtained his medical degree and a Masters in Epidemiology from Brown University.  He currently runs a large Urology practice in South Florida, Z Urology, and lectures regularly on the applications of Biologics for Sexual Dysfunction and all of Urology, and Peer Reviews for multiple medical journals. 

Dr. Zahalsky has been so happy with his results, he established UroCellZ Research, a clinical research group of 20 Sexual Dysfunction experts from around the United States to focus on advancing research and education in the rapidly growing field of Medicine and Urology. 

"It is clear Biologics are the future of Medicine, and it is up to us as clinicians to educate the public and provide the necessary research to advance this field," says Dr. Zahalsky. "I have been treating patients with Biologics for approximately 4 years, and none of them have gone on to have a penile prosthesis."

Questions about the study can be directed to Dr. Michael Zahalsky at 954-714-8200. Dr. Zahalsky is a regularly featured speaker about the use of biologics to treat sexual dysfunction like ED and Peyronie's Disease.

Copyright©2016 PR Newswire.
All rights reserved

Related biology technology :

1. Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement
2. Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound
3. As the life science industry evolves, it is clear that biologics are here to stay!
4. A Homegrown Smile? Atlanta Dentist Examines New Research on the Biological Teeth Replacement
5. Rocky Mountain Biologicals Expands Custom Serum Filtration Facility
6. Synthetic Biologics Reiterates that the Infectious Disease Collaboration with Intrexon Remains in Effect
7. U.S. FDA Grants Fast-Track Designation to Sanofi Pasteur and KaloBios Novel Biologic Candidate for Pseudomonas aeruginosa
8. At Three Months Post Launch, Two-Thirds of Surveyed U.S. Rheumatologists Believe that Initiations of Pfizers Xeljanz in the Rheumatoid Arthritis Treatment Algorithm Will Occur Following at Least Two Biologic Failures
9. Genedata Biologics for Biopharma R&D at Ninth Annual PEGS
10. Partnership between EBSCO Publishing and BioOne Online Journals Adds Scholarly Biological, Ecological and Environment Sciences Articles to EBSCO Discovery Service™
11. Predictive Biomarker Discovery for Oncology Small-Molecules and Biologics - a Webinar Hosted by Xtalks
Post Your Comments:
(Date:6/19/2020)... ... June 18, 2020 , ... The Vitaspace ... is to join forces to radically prolong life and find a way (medicine or ... period. This project was supported by various scientists from all over the world, doctors, ...
(Date:6/11/2020)... ... 09, 2020 , ... Reducing carbon emissions has been and will continue to ... stock market dips, ways to reduce CO2 is something we can’t avoid. , ... the biofuels being produced today are created from recycled cooking oil or crops. Unfortunately, ...
(Date:5/30/2020)... ... 2020 , ... The Conference Forum is pleased to announce ... the unique role of the Chief Medical Officer in the biotech industry. The ... practices and career development of CMOs and Heads of R&D from different therapeutic ...
(Date:5/21/2020)... ... May 21, 2020 , ... Threats to intellectual property, political ... Contrary to conventional wisdom that says the coronavirus pandemic will generally benefit biopharmaceutical ... from the pandemic commercially weaker, dealing with delays in new product launches and ...
Breaking Biology Technology:
(Date:7/1/2020)... ... July 01, 2020 , ... ... and solutions for glioblastoma—the most common and aggressive adult brain cancer—announced today the ... PhD. Senior Fellows are charged with supporting the organization’s initiatives and overall vision. ...
(Date:6/28/2020)... ... 2020 , ... In an upcoming episode scheduled for the fall of 2020, ... solutions (POCT). Check local listings for more info. , Today, the majority of testing ... to labs throughout the country. Results are then available several days later. Now, in ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... gene-to-protein and monoclonal antibody development services, today announced that the company has ... services to the pharmaceutical, diagnostics, and research industries. The decision to pursue ...
Breaking Biology News(10 mins):